Hesperetin as an adjuvant augments protective anti‐tumour immunity responses in B16F10 melanoma by stimulating cytotoxic CD8 + T cells

Comparative evaluation of hesperetin loaded nanoparticles for anticancer activity against C6 glioma cancer cells

(2019) Melike Ersoz et al.   Artificial Cells Nanomedicine and Biotechnology

Clinical Pharmacokinetic and Pharmacodynamic Considerations in the (Modern) Treatment of Melanoma

(2019) Hannah Yejin Kim et al.   CLINICAL PHARMACOKINETICS

Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity

(2019) Shuting Shi et al.   VACCINE

Chemical and Immunological Characteristics of Aluminum-Based, Oil-Water Emulsion, and Bacterial-Origin Adjuvants

(2019) Susana Martiñón et al.   Journal of Immunology Research

TNF-Alpha Inhibition and Other Immunosuppressants in the Development of Uveal and Cutaneous Melanoma

(2019) Gena M. Damento et al.   MAYO CLINIC PROCEEDINGS

Cytotoxic Activity and Memory T Cell Subset Distribution of in vitro-Stimulated CD8+ T Cells Specific for HER2/neu Epitopes

(2019) Maria Kuznetsova et al.   Frontiers in Immunology

Cytolytic Perforin as an Adjuvant to Enhance the Immunogenicity of DNA Vaccines

(2019) Ashish C. Shrestha et al.   Vaccines

Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator’s Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial

(2018) James Larkin et al.   JOURNAL OF CLINICAL ONCOLOGY

CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review

(2018) Bagher Farhood et al.   JOURNAL OF CELLULAR PHYSIOLOGY

TNFα mediated ceramide generation triggers cisplatin induced apoptosis in B16F10 melanoma in a PKCδ independent manner

(2018) Sweta Ghosh et al.   Oncotarget

Immunomodulatory potential of hesperetin and chrysin through the cellular and humoral response

(2017) Aïcha Sassi et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Activation of IRF3 contributes to IFN-γ and ISG54 expression during the immune responses to B16F10 tumor growth

(2017) Zachary Guinn et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Citrus flavanones naringenin and hesperetin improve antioxidant status and membrane lipid compositions in the liver of old-aged Wistar rats

(2016) Marko Miler et al.   EXPERIMENTAL GERONTOLOGY

Natural Killer Cell Recognition of Melanoma: New Clues for a More Effective Immunotherapy

(2016) Raquel Tarazona et al.   Frontiers in Immunology

Effects of Wnt-10b on proliferation and differentiation of murine melanoma cells

(2015) Masayasu Misu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Biological activity of natural flavonoids as impacted by protein flexibility: an example of flavanones

(2015) Fei Ding et al.   Molecular BioSystems

Current status of granulocyte–macrophage colony-stimulating factor in the immunotherapy of melanoma

(2014) Howard L Kaufman et al.   Journal for ImmunoTherapy of Cancer

A DNA vaccine targeting p42.3 induces protective antitumor immunity via eliciting cytotoxic CD8+T lymphocytes in a murine melanoma model

(2013) Hu Liu et al.   Human Vaccines & Immunotherapeutics

Nizatidine, a small molecular compound, enhances killed H5N1 vaccine cell-mediated responses and protects mice from lethal viral challenge

(2013) Shuang Wang et al.   Human Vaccines & Immunotherapeutics

Interleukin-6 and melanoma

(2012) Lise Hoejberg et al.   MELANOMA RESEARCH

Use of Praziquantel as an Adjuvant Enhances Protection and Tc-17 Responses to Killed H5N1 Virus Vaccine in Mice

(2012) Qiang Zou et al.   PLoS One

Clinical Applications of DNA Vaccines: Current Progress

(2011) B. Ferraro et al.   CLINICAL INFECTIOUS DISEASES

Aluminum Adjuvant Dose Guidelines in Vaccine Formulation for Preclinical Evaluations

(2011) Simone Vecchi et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Adjuvants Induce Distinct Immunological Phenotypes in a Bovine Tuberculosis Vaccine Model

(2009) H. M. Vordermeier et al.   Clinical and Vaccine Immunology